title: Conversion from Sandimmune to Neoral in stable renal and pancreas transplant recipients enhances cyclosporine absorption.
authors.affiliation: National Pancreas Transplant Unit, Westmead Hospital, Sydney, Australia.
authors.forename: J R
authors.initials: JR
authors.lastname: Chapman
authors.forename: P J
authors.initials: PJ
authors.lastname: O'Connell
authors.forename: K J
authors.initials: KJ
authors.lastname: Bovington
authors.forename: R D
authors.initials: RD
authors.lastname: Allen
mesh_terms: D000284:Administration, Oral; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004304:Dosage Forms; D016903:Drug Monitoring; D005919:Glomerular Filtration Rate; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D007408:Intestinal Absorption; D007677:Kidney Function Tests; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D016035:Pancreas Transplantation / Q000276:immunology*
chemical_list: D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine